CBGGF

10.9100.00%
AA

Andrew Albert Kucharchuk

Chief Financial Officer

Mr. Andrew Albert Kucharchuk, also known as AL, is Chief Financial Officer of RRE Ventures Acquisition Corp. from February 26, 2026. Mr. Kucharchuk is Chief Financial Officer of Range Capital Acquisition Corp. since August 11, 2025. Mr. Kucharchuk is Chief Financial Officer of Range Capital Acquisition Corp II since May 22, 2025. He is Independent Director of Windtree Therapeutics, Inc. from August 3, 2025. Mr. Kucharchuk serves as Chief Financial Officer of CERo Therapeutics Inc. He served as Chief Financial Officer at ConnectM Technology Solutions Inc. since 2025 until October 2025. He was Director & Chief Financial Officer of Two Hands Corporation from January 3, 2025 to February 20, 2025. Mr. Kucharchuk is Chief Financial Officer of CERo Therapeutics Holdings, Inc. from October 2024. Mr. Kucharchuk served as Chief Financial Officer of Nukkleus Inc. from June 2024 until March 2025. He serves as Chief Financial Officer of Chain Bridge I, since April 1, 2024. He was Chief Financial Officer of Theralink Technologies, Inc. from May 5, 2023 to June 2024. He served as Chief Operating Officer of Adhera Therapeutics, Inc. since September 30, 2022 until September 2024 and served as its Acting Chief Financial Officer and Chief Business Officer. He was Vice Chairman of Adhera Therapeutics, Inc. since May 2022 and is its Director since July 7, 2020. He was Corporate Development and Investor Relations at Adhera Therapeutics, Inc. and served as its Chief Financial Officer from September 2022 to August 2023. He served as the Chief Executive Officer at Adhera Therapeutics, Inc. since July 7, 2020 until September 30, 2022 and served as Chairman of the Board from July 7, 2020 to May 2022 and also served as its Chief Financial Officer from September 2022 to August 2023. He served as an Acting Chief Financial Officer at OncBioMune Pharmaceuticals, Inc. (also known as Theralink Technologies, Inc.) since June 2020 until September 24, 2020. He served as Director at Theralink Technologies, Inc. since May 28, 2020 until September 2023 and previously from September 2015 to March 2017 and served as its Chief Financial Officer since 2009 until June 5, 2020. He was the President of OncBioMune Pharmaceuticals, Inc. from September 2, 2015 until June 5, 2020 and was its Chief Executive Officer from November 8, 2019 until June 5, 2020. Mr. Kucharchuk oversees the business and administrative processes. He also directs business development efforts including the expansion of operations to accommodate increased research and clinical development. He served as Chief Financial Officer at OncBioMune, Inc. from 2009 to September 2015. He served as Chief Operating Officer, Principal and Executive Vice President at OncBioMune Pharmaceuticals, Inc. He served as a Director of OncBioMune Pharmaceuticals, Inc. from September 2, 2015 to March 10, 2017 and he served as a member of the board of directors of OncBioMune from June 2020 until September 2023. He holds B.A. in Ag Business from Louisiana State University. He holds MBA with a Finance at Tulane University and B.A. in Business from Freeman School of Business.

公司职务